Elevated LVEDP, Chronic Pulmonary Oedema and Valve Disease
Keywords:increased LVEDP, chronic pulmonary oedema, valvular heart disease
As part of ageing and with increased longevity of older people there has been a rise of those with left ventricular diastolic dysfunction (LVDD) and increased left ventricular end diastolic pressure (LVEDP). Comorbidities like hypertension, diabetes, chronic kidney disease, coronary artery disease and others appear to be contributing to this . Chronic interstitial pulmonary oedema may be a part of the presentation of those with elevated LVEDP/LVDD. Progressive valvular heart disease may also complicate the picture and make clinical decision-making difficult. This case report discusses these issues.
Ponikowski P, Voors AA, Anker SD, et al. . 2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 2016;37:2129–200.doi:10.1093/eurheartj/ehw128.
P Banerjee, A motiwala, HM Mustafa et al. Does left ventricular diastolic dysfunction progress through stages? Insights from a community heart failure study. Int J Cardiol 2016 Jul 5;221:850-854, http://dx.doi.org/10.1016/j.ijcard.2016.07.091.
Mérillon JP, Ennezat PV, Guiomard A, Masquet-Gourgon C, , Gourgon R. Left ventricular performance is closely related to the physical properties of the arterial system: Landmark clinical investigations in the 1970s and 1980s. Arch Cardiovasc Dis. 2014 Oct;107(10):554-62. doi: 10.1016/j.acvd.2014.08.001. Epub 2014 Oct 8.
Banerjee P. Heart failure: a story of damage, fatigue and injury? Open Heart 2017;4:e000684. doi: 10.1136/openhrt-2017-000684.
Lai-Jing Du, Ping-Shuan Dong, Jing-Jing Jia . Association between left ventricular end-diastolic pressure and coronary artery disease as well as its extent and severity. Int J Clin Exp Med. 2015; 8(10): 18673–18680.
Rajaram S, Swift AJ, Condliffe R, et aL. CT features of pulmonary arterial hypertension and its major subtypes: a systematic CT evaluation of 292 patients from the ASPIRE Registry. Thorax Published Online First: 18 December 2014. doi: 10.1136/thoraxjnl-2014-206088.
Hansdottir S, Groskreutz DJ, Gehlbach BK. WHO's in second?: A practical review of World Health Organization group 2 pulmonary hypertension. Chest, 144 (2013), pp. 638-650.
Heart failure with preserved ejection fraction. A clinical crisis. Banerjee P.
Int J Cardiol. 2016 Feb 1;204:198-9. doi: 10.1016/j.ijcard.2015.11.170. Epub 2015 Nov 24. PMID: 26670172.
Shewan LG, Coats AJS, Henein M. Requirements for ethical publishing in biomedical journals. International Cardiovascular Forum Journal 2015;2:2 DOI: 10.17987/icfj.v2i1.4
Authors who publish with this journal agree to the following terms:
a. The authors will retain copyright under a Creative Commons Attribution License (CC-BY 4.0) that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
b. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
c. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).